At the yearly PPTA meeting in Brussels, Paolo Marcucci has been elected as new chairman of the Global Board of Directors of the Plasma Protein Therapeutics Association.
Paolo Marcucci has served on the PPTA Global Board of Directors since 2008. “It will be a great honor and privilege to serve as the new chairman of PPTA. I look forward to continuing the work of my predecessor to improve patient access to critically needed safe plasma protein therapies” Mr. Marcucci said.
Mr. Marcucci has coordinated and directed research projects related to plasma proteins, coagulation factors and vaccines that have resulted in new pharmaceutical products and purification methods that contribute to product efficacy and safety.
“It will be a pleasure to work with Paolo who will bring a new dimension to this role. It is also nice that he is going to lead this Board, knowing that his father, Guelfo Marcucci was one of the founders of PPTA” said Jan M. Bult, PPTA President and CEO.
Mr. Marcucci succeeds Paul Perreault, CSL, who served as chair since 2012 and will remain on the Board.
PPTA’s Global Board is committed to ensuring patient access to therapies, the safety and quality of plasma collection and the manufacturing of plasma protein therapies and sustained innovation that helps save and improve lives throughout the world.
